Legal & General Group PLC Moon Lake Immunotherapeutics Transaction History
Legal & General Group PLC
- $390 Billion
- Q2 2025
A detailed history of Legal & General Group PLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Legal & General Group PLC holds 20,905 shares of MLTX stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,905
Previous 19,480
7.32%
Holding current value
$1.16 Million
Previous $761,000
29.57%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MLTX
# of Institutions
160Shares Held
54.5MCall Options Held
815KPut Options Held
666K-
Bvf Inc San Francisco, CA19.8MShares$1.09 Billion36.63% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$470 Million40.43% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.15MShares$230 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.61MShares$145 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.67MShares$92.7 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $2.04B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...